Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-09-14Clinical Trial Update: Imaging of Peri-operative (periOP) Lung Injury [Phase 2]
Phase 2 clinical trial update on imaging of peri-operative lung injury (periOP) terminated with results posted.
-
CLINICAL_TRIALS withdrawal · 2021-09-13Clinical Trial Update: Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD [Phase 3]
Phase 3 trial investigating ipratropium/levalbuterol fixed-dose combination versus salbutamol/ipratropium free combination for acute broncho…
-
CLINICAL_TRIALS trial_result · 2021-09-09Clinical Trial Update: A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)
A completed clinical trial using health insurance data to study treatment in patients newly diagnosed with chronic obstructive pulmonary dis…
-
CLINICAL_TRIALS trial_result · 2021-08-30Clinical Trial Update: Early Intervention Efficacy in COPD
A completed clinical trial investigating early intervention efficacy in chronic obstructive pulmonary disease (COPD) with results posted in …
-
CLINICAL_TRIALS trial_result · 2021-08-24Clinical Trial Update: An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. [Phase 2]
Phase 2 trial comparing three doses of BEA 2180 BR to tiotropium and placebo in COPD; study completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-08-18FDA Approved: ADVAIR HFA — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for Advair HFA, a combination inhaled corticosteroid and long-acting beta-agonist from GlaxoSmit…
-
FDA approval · 2021-08-18FDA Approved: VENTOLIN HFA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Ventolin HFA (albuterol sulfate) submitted by GlaxoSmithKline LLC.
-
CLINICAL_TRIALS trial_result · 2021-08-18Clinical Trial Update: Capnometry-Assisted Breathing Training for COPD [Phase 2]
Phase 2 clinical trial update for capnometry-assisted breathing training in chronic obstructive pulmonary disease has completed with results…
-
CLINICAL_TRIALS trial_result · 2021-08-12Clinical Trial Update: Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) Study [Phase 4]
Phase 4 clinical trial evaluating theophylline in combination with steroids for chronic obstructive pulmonary disease has completed with res…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial update investigating effects of long-acting bronchodilators on cardiac autonomic control in COPD.
-
CLINICAL_TRIALS trial_result · 2021-07-26Clinical Trial Update: Anti-viral Effects of Azithromycin in Patients With Asthma and COPD [Phase 4]
A Phase 4 clinical trial investigates the anti-viral effects of azithromycin in patients with asthma and chronic obstructive pulmonary disea…
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study) [Phase 3]
A Phase 3 clinical trial update aimed at reducing diagnostic error to improve patient safety in COPD and asthma has completed with results p…
-
CLINICAL_TRIALS research · 2021-07-20Clinical Trial Update: Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study
A retrospective claims study characterizing COPD patients initiating tio+olo or other maintenance therapies in the US and UK.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Short Compared With Standard Duration of Antibiotic Treatment for AECOPD [Phase 2]
Phase 2 trial comparing short versus standard duration of antibiotic treatment for acute exacerbation of chronic obstructive pulmonary disea…
-
FDA approval · 2021-07-09FDA Approved: FLUTICASONE PROPIONATE AND SALMETEROL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental NDA for Fluticasone Propionate and Salmeterol (Teva) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: A Phase 2a Study to Assess Safety, Daily Symptoms, PK, and Biomarkers of YPL-001 in COPD Patients [Phase 2]
Phase 2a trial evaluating safety, daily symptoms, pharmacokinetics, and biomarkers of YPL-001 in COPD patients has completed with posted res…
-
FDA approval · 2021-06-22FDA Approved: ARFORMOTEROL TARTRATE INHALATION — Original Application (Slate Run Pharmaceuticals)
FDA approved Slate Run Pharmaceuticals' ARFORMOTEROL TARTRATE INHALATION for the maintenance treatment of chronic obstructive pulmonary dise…
-
FDA approval · 2021-06-22FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA's original application for arformoterol tartrate, a generic long-acting beta-agonist for maintenance treatment of chr…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease [Phase 2]
Phase 2 dose-ranging study of CHF 5259 inhalation in COPD completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng) [Phase 4]
Phase 4 clinical trial update evaluating Zhuli Capsule for phlegm-heat syndrome in chronic obstructive pulmonary disease and chronic bronchi…
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific [NA]
Clinical trial update reporting on occurrence of potential bacterial and viral pathogens in stable COPD and during acute exacerbations in As…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Nebulizer Versus Dry Powdered Inhalers for Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]
Phase 4 trial comparing nebulizer therapy to dry powder inhalers in COPD patients; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-08Clinical Trial Update: Juno Perth Clinical Trial [NA]
Clinical trial update for the Juno Perth study (NCT02317042) shows termination with results posted in 2021; no phase information available.
-
CLINICAL_TRIALS trial_result · 2021-06-07Clinical Trial Update: Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients [NA]
Clinical trial update for sleep and daytime use of humidified nasal high-flow oxygen in COPD outpatients; study completed with results poste…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Integrating Care After Exacerbation of COPD [NA]
Clinical trial update related to integrating care after COPD exacerbation; study completed with posted results.